deliver significant clinical benefit

to patients worldwide. Arbor intends to develop and commercialize its core

technologies in varying combinations, giving the company the opportunity to

create a portfolio of product offerings. Currently in clinical trials, Arbor

is developing a tissue heart valve family of products designed for improved

performance over existing valves and compatible implantation tools that

simplify and speed valve replacement surgery.